These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 28460112)

  • 21. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T
    Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Sutherland CJ; Lansdell P; Sanders M; Muwanguzi J; van Schalkwyk DA; Kaur H; Nolder D; Tucker J; Bennett HM; Otto TD; Berriman M; Patel TA; Lynn R; Gkrania-Klotsas E; Chiodini PL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28137810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
    Price RN; Uhlemann AC; van Vugt M; Brockman A; Hutagalung R; Nair S; Nash D; Singhasivanon P; Anderson TJ; Krishna S; White NJ; Nosten F
    Clin Infect Dis; 2006 Jun; 42(11):1570-7. PubMed ID: 16652314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.
    Gadalla NB; Adam I; Elzaki SE; Bashir S; Mukhtar I; Oguike M; Gadalla A; Mansour F; Warhurst D; El-Sayed BB; Sutherland CJ
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5408-11. PubMed ID: 21896916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.
    Nega D; Assefa A; Mohamed H; Solomon H; Woyessa A; Assefa Y; Kebede A; Kassa M
    PLoS One; 2016; 11(4):e0154618. PubMed ID: 27128799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
    Dahlström S; Aubouy A; Maïga-Ascofaré O; Faucher JF; Wakpo A; Ezinmègnon S; Massougbodji A; Houzé P; Kendjo E; Deloron P; Le Bras J; Houzé S
    Antimicrob Agents Chemother; 2014; 58(1):1-10. PubMed ID: 24100489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
    Ochola-Oyier LI; Okombo J; Mwai L; Kiara SM; Pole L; Tetteh KK; Nzila A; Marsh K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1770-5. PubMed ID: 25534732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.
    Sondo P; Derra K; Diallo Nakanabo S; Tarnagda Z; Kazienga A; Zampa O; Valéa I; Sorgho H; Owusu-Dabo E; Ouédraogo JB; Guiguemdé TR; Tinto H
    PLoS One; 2016; 11(3):e0151565. PubMed ID: 27031231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
    Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
    J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.
    Dama S; Niangaly H; Ouattara A; Sagara I; Sissoko S; Traore OB; Bamadio A; Dara N; Djimde M; Alhousseini ML; Goita S; Maiga H; Dara A; Doumbo OK; Djimde AA
    Malar J; 2017 Feb; 16(1):59. PubMed ID: 28148267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.
    Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA
    Malar J; 2014 Nov; 13():430. PubMed ID: 25403945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
    Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
    Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
    Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P
    Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.
    Dieye B; Affara M; Sangare L; Joof F; Ndiaye YD; Gomis JF; Ndiaye M; Mbaye A; Diakite M; Sy N; Mbengue B; Deme AB; Daniels R; Ahouidi AD; Dieye T; Abdullahi A; Doumbia S; Ndiaye JL; Diarra A; Ismaela A; Coulibaly M; Welty C; Ngwa AA; Shaffer J; D'Alessandro U; Volkman SK; Wirth DF; Krogstad DJ; Koita O; Nwakanma D; Ndiaye D
    Am J Trop Med Hyg; 2016 Nov; 95(5):1054-1060. PubMed ID: 27549635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
    Okafor HU; Shu EN; Oguonu T
    J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh.
    Haque R; Thriemer K; Wang Z; Sato K; Wagatsuma Y; Salam MA; Akther S; Akter J; Fukuda M; Miller RS; Noedl H
    Am J Trop Med Hyg; 2007 Jan; 76(1):39-41. PubMed ID: 17255226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.
    Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP
    Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.